Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome

M. Boyadzhiev, L. Marinov, V. Boyadzhiev, V. Iotova, I. Aksentijevich, Sophie Hambleton

Open source

DOI
10.25405/ncl.34381239.v1
Published
2026
Container
Not recorded
Publisher
Newcastle University
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.25405/ncl.34381239.v1,
  title = {Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome},
  author = {M. Boyadzhiev and L. Marinov and V. Boyadzhiev and V. Iotova and I. Aksentijevich and Sophie Hambleton},
  year = {2026},
  doi = {10.25405/ncl.34381239.v1},
  url = {https://doi.org/10.25405/ncl.34381239.v1}
}

RIS

TY  - JOUR
TI  - Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome
AU  - M. Boyadzhiev
AU  - L. Marinov
AU  - V. Boyadzhiev
AU  - V. Iotova
AU  - I. Aksentijevich
AU  - Sophie Hambleton
PY  - 2026
DO  - 10.25405/ncl.34381239.v1
UR  - https://doi.org/10.25405/ncl.34381239.v1
ER  - 

APA

Boyadzhiev, M., Marinov, L., Boyadzhiev, V., Iotova, V., Aksentijevich, I., & Hambleton, S. (2026). Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome. https://doi.org/10.25405/ncl.34381239.v1

Source records